Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 15/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 10/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7002695 | 0.89 | PTGS2 (0.42) | PTGS2PTGS1 | |
| SCHEMBL6999679 | 0.86 | PTGS2 (0.36) | PTGS2PTGS1CA2CA9CA1 | |
| SCHEMBL6999625 | 0.81 | PTGS2 (0.39) | PTGS2PTGS1 | |
| SCHEMBL6992672 | 0.81 | PTGS2 (0.51) | PTGS2PTGS1 | |
| SCHEMBL6998585 | 0.80 | PTGS2 (0.39) | PTGS2PTGS1CA2CA9KDM4E | |
| SCHEMBL6993233 | 0.80 | PTGS2 (0.49) | PTGS2PTGS1CA2CA9CA1 | |
| SCHEMBL7004184 | 0.79 | PTGS2 (0.46) | PTGS2PTGS1 | |
| SCHEMBL6999688 | 0.78 | PTGS2 (0.60) | PTGS2PTGS1CA2CA9CA1 | |
| SCHEMBL6993821 | 0.78 | PTGS2 (0.50) | PTGS2PTGS1CA2CA1 | |
| SCHEMBL6999628 | 0.78 | PTGS2 (0.44) | PTGS2PTGS1CA2CA9KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | claimed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | claimed |
| EP-1109799-B1 | 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS | PACIFIC CORP (KR) | 2003-12-17 | — | — | EP | disclosed |
| US-6492416-B1 | TREATING INFLAMMATION AND ASSOCIATED DISORDERS | PACIFIC CORPORATION (KR) | 2002-12-10 | — | — | US | disclosed |